Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin Dosing by Lean Body Weight in Cardiac Surgery
NCT03113708Phase 4Unknown
- Sponsor
- Adiyaman University Research Hospital
- Start
- Apr 2017
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 4 trial of heparin in heart valve disease, sponsored by Adiyaman University Research Hospital. Status: unknown.
02
Drugs
heparin
03
Conditions
heart valve disease
Beyond the preview
Go deeper on NCT03113708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113708.